Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C.
暂无分享,去创建一个
J. Wetzels | R. de Groot | M. D. de Jonge | J. Langereis | M. van der Flier | N. C. van de Kar | K. Wijnsma | B. van den Broek